Aesthetic Empire: Dr. Calobrace Joins CPP in Landmark Partnership

LOUISVILLE, Ky. – January 14, 2026 – In a significant move that underscores the rapid consolidation within the U.S. aesthetic medicine market, Calo Aesthetics, the acclaimed practice of internationally recognized plastic surgeon Dr. Brad Calobrace, has officially joined Cosmetic Physician Partners (CPP). The partnership integrates one of Kentucky’s premier plastic surgery clinics into what is quickly becoming one of the nation's largest networks of aesthetic centers.

This alliance represents a strategic fusion of elite surgical expertise and a powerful, rapidly scaling business platform. For Calo Aesthetics, with its established locations in Louisville and Lexington, the move provides the resources to accelerate growth and expand its reach. For CPP, the acquisition of a practice led by a surgeon of Dr. Calobrace's caliber is a major validation of its model and a significant enhancement of its brand prestige.

The Consolidation Wave in Aesthetic Medicine

The partnership arrives amidst a period of explosive growth and transformation in the aesthetic industry. The global aesthetic medicine market, valued at nearly $90 billion in 2024, is projected to soar to almost $240 billion by 2033, driven by an aging population and soaring demand for both minimally invasive and surgical procedures. This lucrative landscape has attracted significant investment, fueling a powerful trend of market consolidation.

Cosmetic Physician Partners has emerged as a key player in this trend. Founded in 2021, CPP has pursued an aggressive growth strategy, expanding from just 10 clinics in late 2022 to over 60 locations nationwide today. The network, which reported generating over $100 million in revenue as early as mid-2023, has distinguished itself with a “physician-led” model. Unlike traditional private equity buyouts that can sideline physician founders, CPP’s structure allows doctors to retain equity and clinical control, while the central organization manages administrative burdens like marketing, HR, and IT.

This model has proven attractive to practice owners, enabling a string of high-profile acquisitions throughout 2025, including Radiant Divine Medical Spa, Maloney Plastic Surgery, and Bucky Plastic Surgery. The addition of Calo Aesthetics is the latest and arguably one of the most significant jewels in CPP’s expanding crown.

Fusing Surgical Mastery with National Scale

At the heart of this deal is the sterling reputation of Dr. Brad Calobrace. A board-certified plastic surgeon and a Fellow of the American College of Surgeons, Dr. Calobrace is widely regarded as a thought leader, particularly for his innovative techniques in breast surgery and body contouring. His work is extensively published in peer-reviewed journals, and he is a frequent lecturer at international conferences and a past board member of the American Society for Aesthetic Plastic Surgery (ASAPS).

This level of expertise is precisely what CPP seeks to leverage. “Dr. Calobrace is an inspirational leader in plastic surgery whose vision and expertise are shaping the future of aesthetic medicine globally,” said Daniel Schacter, CEO of CPP, in the official announcement. By integrating such a prominent figure, CPP not only expands its geographic footprint but also elevates the clinical authority of its entire network.

For his part, Dr. Calobrace views the partnership as a vehicle for advancing the field. “This partnership marks the next chapter in our mission to set a national standard for surgical and non-surgical aesthetics,” he stated. “With CPP’s support, we can expand access to transformative procedures, enhance patient experiences, and accelerate the growth of Calo Aesthetics and CaloSpa.”

The Future of Patient Care in a Corporate Era

The consolidation of independent practices into large networks raises important questions for patients. Proponents argue that such partnerships democratize access to high-quality care, allowing best practices and cutting-edge technologies from leading centers to be disseminated across a wider network. The economies of scale can lead to enhanced facilities and a broader menu of services, benefiting consumers in markets previously served by smaller, less-resourced clinics.

However, a common concern is whether the personalized, high-touch patient experience that defines elite private practices can survive within a larger corporate structure. The success of a practice like Calo Aesthetics is built not only on surgical outcomes but also on a reputation for individualized care and patient trust, cultivated over many years.

Both parties appear keenly aware of this challenge. Dr. Calobrace’s statement explicitly highlights the goal of accelerating growth “while maintaining the personalized care our patients anticipate.” The ability of the combined entity to deliver on this promise will be critical to its long-term success. The partnership model, which keeps physician leaders like Dr. Calobrace actively involved, is designed to ensure that clinical excellence and patient-centric values remain at the forefront, even as the business scales.

As CPP continues its national expansion, this partnership will serve as a crucial test case for a new paradigm in aesthetic medicine—one that attempts to seamlessly blend the art of individual surgical mastery with the science of building a scalable, national business. The outcome will likely influence the strategic direction of the entire industry for years to come.